SCHEMBL7300759

SCHEMBL7300759

CCCCc1nc(C(O)C(C)(C)C)c(C(N)=O)n1Cc1ccc(-c2ccccc2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.52
ACHE P22303 1/20 0.50
AGTR1 P30556 1/20 0.49
AGTR2 P50052 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308645 0.95 PPARG (0.54) PPARG
SCHEMBL7340692 0.94 PPARG (0.51) PPARGACHEAGTR1AGTR2
SCHEMBL7307434 0.93 PPARG (0.52) PPARGACHEAGTR1AGTR2
SCHEMBL7301439 0.93 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL7302962 0.93 PPARG (0.51) PPARGACHEAGTR1AGTR2
SCHEMBL7308590 0.92 PPARG (0.51) PPARGACHEAGTR1AGTR2
SCHEMBL7304547 0.92 ACHE (0.50) ACHEAGTR1AGTR2
SCHEMBL7303275 0.90 AGTR1 (0.61) AGTR1AGTR2
SCHEMBL8566436 0.88 PPARG (0.54) PPARGAGTR1AGTR2
SCHEMBL7299333 0.88 PPARG (0.54) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed